These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 1580158)
1. Kawasaki disease in a father and son. Iwata F; Hanawa Y; Takashima H; Shimoura K; Nishibayashi Y Acta Paediatr Jpn; 1992 Feb; 34(1):84-6. PubMed ID: 1580158 [TBL] [Abstract][Full Text] [Related]
2. HLA Bw51 is increased in mucocutaneous lymph node syndrome in Israeli patients. Keren G; Danon YL; Orgad S; Kalt R; Gazit E Tissue Antigens; 1982 Aug; 20(2):144-6. PubMed ID: 6958087 [No Abstract] [Full Text] [Related]
3. Genetic variants in the HLA-G region are associated with Kawasaki disease. Kim JJ; Hong SJ; Hong YM; Kim S; Kang MJ; Kim KJ; Seo EJ; Yoo HW; Cheong HS; Shin HD; Park IS; Lee JK Hum Immunol; 2008 Dec; 69(12):867-71. PubMed ID: 18976687 [TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease in a father and daughter. Kaneko K; Obinata K; Katsumata K; Tawa T; Hosaka A; Yamashiro Y Acta Paediatr; 1999 Jul; 88(7):791-2. PubMed ID: 10447146 [No Abstract] [Full Text] [Related]
7. Kawasaki disease: infection, immunity and genetics. Wang CL; Wu YT; Liu CA; Kuo HC; Yang KD Pediatr Infect Dis J; 2005 Nov; 24(11):998-1004. PubMed ID: 16282937 [TBL] [Abstract][Full Text] [Related]
8. Genetic epistasis between killer immunoglobulin-like receptors and human leukocyte antigens in Kawasaki disease susceptibility. Bossi G; Mannarino S; Pietrogrande MC; Salice P; Dellepiane RM; Cremaschi AL; Corana G; Tozzo A; Capittini C; De Silvestri A; Tinelli C; Pasi A; Martinetti M Genes Immun; 2015 Oct; 16(7):481-7. PubMed ID: 26335810 [TBL] [Abstract][Full Text] [Related]
9. Imputation of class I and II HLA loci using high-density SNPs from ImmunoChip and their associations with Kawasaki disease in family-based study. Shrestha S; Wiener HW; Aissani B; Shendre A; Tang J; Portman MA Int J Immunogenet; 2015 Jun; 42(3):140-6. PubMed ID: 25809546 [TBL] [Abstract][Full Text] [Related]
10. Epidemic and endemic HLA-B and DR associations in mucocutaneous lymph node syndrome. Krensky AM; Grady S; Shanley KM; Berenberg W; Yunis EJ Hum Immunol; 1983 Feb; 6(2):75-7. PubMed ID: 6572621 [TBL] [Abstract][Full Text] [Related]
11. An immune-molecular hypothesis supporting infectious aetiopathogenesis of Kawasaki disease in children. Capittini C; Emmi G; Mannarino S; Bossi G; Dellepiane RM; Salice P; Pietrogrande MC; Pasi A; De Silvestri A; Tinelli C; Martinetti M Eur J Immunol; 2018 Mar; 48(3):543-545. PubMed ID: 29193035 [TBL] [Abstract][Full Text] [Related]
12. Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient. Laxer RM; Cameron BJ; Silverman ED J Rheumatol; 1988 Mar; 15(3):515-6. PubMed ID: 3379628 [TBL] [Abstract][Full Text] [Related]
13. [Kawasaki syndrome. Current aspects]. Bénichou JJ; Labrune B Ann Pediatr (Paris); 1988 May; 35(5):297-301. PubMed ID: 3400963 [No Abstract] [Full Text] [Related]
14. HLA antigens in mucocutaneous lymph node syndrome in New England. Krensky AM; Berenberg W; Shanley K; Yunis EJ Pediatrics; 1981 May; 67(5):741-3. PubMed ID: 7255009 [TBL] [Abstract][Full Text] [Related]
15. HLA-B*54:01 Is Associated With Susceptibility to Kawasaki Disease. Kwon YC; Sim BK; Yu JJ; Yun SW; Yoon KL; Lee KY; Kil HR; Kim GB; Han MK; Song MS; Lee HD; Jang GY; Hong YM; Kwon OJ; Oh HB; Lee JK; ; Circ Genom Precis Med; 2019 Jan; 12(1):e002365. PubMed ID: 31017802 [No Abstract] [Full Text] [Related]